🔎 Trials Near Me

Domov › Sladkorna bolezen tipa 2 › Florida › Orlando

Klinične študije za Sladkorna bolezen tipa 2 v Orlando, FL

24 študij za Sladkorna bolezen tipa 2 išče udeležence na lokacijah v Orlando in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Vključevanje udeležencevFaza 2
  • Florida Institute For Clinical Research, LLC, Orlando
  • K2 Medical Research - Maitland, Maitland · 6 mi stran
  • Omega Research Orlando, Altamonte Springs · 9 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07783802

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Vključevanje udeležencevFaza 3
  • Florida Institute for Clinical Research, Orlando
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Vključevanje udeležencevFaza 3
  • Conquest Research, Winter Park · 5 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07754461

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • Clinical Site Partners, LLC dba Flourish Research, Winter Park · 5 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Vključevanje udeležencevFaza 3
  • Research Site, Ocoee · 10 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • AURORA-2 Clinical Site, Winter Park · 5 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743450

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

Vključevanje udeležencevFaza 2
  • Conquest Research LLC - Winter Park, Winter Park · 5 mi stran
Starost 18–75 · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT07340320

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Vključevanje udeležencevFaza 2
  • West Orange Endocrinology, Ocoee · 10 mi stran
Starost 18–75 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07415954

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Vključevanje udeležencevFaza 2
  • Central Florida Kidney Specialists Oakwater, Orlando
Starost 18–80 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07271186

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Vključevanje udeležencevFaza 3
  • Research Site, Orlando
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07662213

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Vključevanje udeležencevFaza 2
  • Conquest Research, Winter Park · 5 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07296484

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • Innovus Clinical, Kissimmee · 16 mi stran
Starost 10–18 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07282613

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Vključevanje udeležencevFaza 3
  • Florida Institute for Clinical Research, Orlando
  • Conquest Research - Winter Park, Winter Park · 5 mi stran
Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07684144

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

Vključevanje udeležencevFaza 3
  • Research Site, Orlando
  • Research Site, Ocoee · 10 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07662135

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

Vključevanje udeležencevFaza 3
  • Research Site, Orlando
Starost 18 in več · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT07662044

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

Vključevanje udeležencevOpazovalna študija
  • Research Site, Ocoee · 10 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT07606066

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Vključevanje udeležencevFaza 2
  • Charter Research, Orlando
  • AdventHealth Translational Research Institute, Orlando
Starost 18–75 · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT07527650

Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis

Vključevanje udeležencevVabljeni zdravi prostovoljci
  • AdventHealth Translational Research Institute, Orlando
Starost 25–55 · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT06993454

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Vključevanje udeležencevFaza 3
  • AdventHealth Orlando, Orlando
Starost 10–17 · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06739122

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

Vključevanje udeležencevFaza 3
  • Research Site, Ocoee · 10 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT07664553

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

Vključevanje udeležencevFaza 2
  • Flourish Research Orlando, Winter Park · 5 mi stran
Starost 18–70 · Vsi spoli · Posodobljeno 15. jun. 2026 · NCT07502508

Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

Vključevanje udeležencevFaza 2
  • Florida Institute for Clinical Research LLC, Orlando
Starost 18 in več · Vsi spoli · Posodobljeno 18. mar. 2026 · NCT07282743

Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency

Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
  • Orlando Clinical Research Center (OCRC), Orlando
Starost 18–80 · Vsi spoli · Posodobljeno 13. mar. 2026 · NCT07385547

The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults

Vključevanje udeležencevVabljeni zdravi prostovoljci
  • Translational Research Institute for Metabolism and Diabetes, Orlando
Starost 60–80 · Vsi spoli · Posodobljeno 13. mar. 2025 · NCT03761446

Študije za Sladkorna bolezen tipa 2 v drugih mestih

Druge študije v Orlando

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.